Kestra Medical Technologies (NASDAQ:KMTS) Shares Down 4.9% - What's Next?

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Get Free Report)'s stock price fell 4.9% during mid-day trading on Friday . The stock traded as low as $17.82 and last traded at $17.83. 37,881 shares were traded during mid-day trading, a decline of 79% from the average session volume of 184,527 shares. The stock had previously closed at $18.75.

Analyst Ratings Changes

KMTS has been the topic of a number of recent research reports. The Goldman Sachs Group lowered their target price on Kestra Medical Technologies from $24.00 to $23.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 16th. Wells Fargo & Company initiated coverage on Kestra Medical Technologies in a research note on Monday, March 31st. They set an "overweight" rating and a $28.00 target price on the stock. Wolfe Research initiated coverage on Kestra Medical Technologies in a research note on Monday, March 31st. They set an "outperform" rating and a $29.00 target price on the stock. Piper Sandler initiated coverage on Kestra Medical Technologies in a research note on Monday, March 31st. They set an "overweight" rating and a $27.00 target price on the stock. Finally, Stifel Nicolaus initiated coverage on Kestra Medical Technologies in a research note on Monday, March 31st. They set a "buy" rating and a $28.00 target price on the stock. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat.com, Kestra Medical Technologies has an average rating of "Moderate Buy" and a consensus target price of $27.50.

Kestra Medical Technologies Price Performance

The business has a 50-day moving average of $22.76.

Kestra Medical Technologies (NASDAQ:KMTS - Get Free Report) last issued its quarterly earnings results on Monday, April 14th. The company reported ($1.25) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.64) by ($0.61). During the same period last year, the business earned ($1.18) earnings per share.

Institutional Investors Weigh In On Kestra Medical Technologies

A number of large investors have recently added to or reduced their stakes in the stock. Jane Street Group LLC acquired a new stake in shares of Kestra Medical Technologies in the 1st quarter valued at $756,000. Woodline Partners LP acquired a new stake in shares of Kestra Medical Technologies in the 1st quarter valued at $2,510,000. Yu Fan acquired a new stake in shares of Kestra Medical Technologies in the 1st quarter valued at $56,880,000. Zimmer Partners LP acquired a new stake in shares of Kestra Medical Technologies in the 1st quarter valued at $374,000. Finally, Millennium Management LLC acquired a new stake in shares of Kestra Medical Technologies in the 1st quarter valued at $11,036,000.

Kestra Medical Technologies Company Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.